Key strengths include high profitability with strong margins, robust and consistent operating and free cash flow, a conservative net debt position with ample liquidity, and a powerful competitive position in Brazil’s regulated medical education market. The integrated offering – from undergraduate education to continuing education and digital practice tools – deepens customer relationships and supports recurring revenue. The balance of strong cash generation and disciplined but active investment provides a solid foundation for long‑term value creation.

Main risks stem from regulatory exposure in Brazil’s education sector, where changes in rules around medical seats or tuition could affect growth and margins. The heavy reliance on intangible, acquisition‑driven assets brings integration and impairment risk if acquired schools or platforms underperform expectations. Significant interest expenses, despite low net leverage, show that financing choices still matter for the bottom line. On the operational side, maintaining leadership in digital health tools requires ongoing innovation, and failure to keep pace with technology shifts could weaken part of the moat.

The overall picture suggests a resilient, high‑margin business with a clear competitive edge in a structurally constrained market and a promising digital expansion story. As long as demand for medical education and digital practice tools in Brazil remains strong and regulation stays broadly supportive, Afya appears well placed to continue generating solid profits and cash flows. Future performance will largely depend on how effectively it balances growth through acquisitions and new seats with disciplined capital allocation, and on whether its digital and AI initiatives can keep its physician‑centric ecosystem ahead of emerging competitors.